SHANGHAI, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Chemspec International Limited (NYSE: CPC; "Chemspec" or the "Company"), a leading China-based contract manufacturer of highly-engineered specialty chemicals, today announced that it will attend following upcoming investor conferences in November, 2009.
Credit Suisse China Investment Conference
Event: One-on-One meetings
Date and time: November 16-17, 2009
Location: Shenzhen InterContinental
Participants: Carol Fang, Investor Relations Manager
Oppenheimer 4th Annual Industrials Conference
Event: Formal Presentation, Q&A, One-on-One meetings
Date: November 17-18, 2009
Location: Room 5.07
Millennium Broadway, New York City
Presentation Time: 9:30 a.m. Wednesday, November 18, 2009
Participants: Bing Zhu, Chief Financial Officer
2009 Brean Murray China Growth Conference
Event: Formal Presentation, Q&A, One-on-One meetings
Date: November 19-20, 2009
Location: Room 3.02
Millennium Broadway, New York City
Presentation Time: 10:40 a.m. Friday, November 20, 2009
Participants: Bing Zhu, Chief Financial Officer
For more information about these three conferences, please contact the investment banks directly.
About Chemspec
Chemspec is a leading China-based contract manufacturer of highly engineered specialty chemicals and the largest manufacturer of fluorinated specialty chemicals in China based on sales. In manufacturing specialty chemicals, Chemspec also provides process design and process development services, which enable efficient and rapid production of specialty chemicals that are incorporated into the products of Chemspec’s end users. Chemspec’s customers and end users include electronics, pharmaceutical and agrochemical companies. For more information, please visit http://www.chemspec.com.cn .
Safe Harbor Statements
This announcement contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in Chemspec’s filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1, as amended from time to time. Chemspec does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For further information, please contact:
Chemspec International Ltd.
In Shanghai
Bing Zhu
Chief Financial Officer
Tel: +86-21-6363-8108
Email: ir@chemspec.com.cn
Christensen
In New York
Kathy Li
Tel: +1-212-618-1978
Email: kli@christensenir.com
In Hong Kong
Tip Fleming
Tel: +852-9212-0684
Email: tfleming@christensenir.com
